SCHEDULE 13G: Laurence W. Lytton Discloses 6.8% Stake in Xtant Medical Holdings, Inc.
Beneficial Ownership Disclosure
Laurence W. Lytton has filed a Schedule 13G, reporting beneficial ownership of 6.8% of Xtant Medical Holdings, Inc.'s common stock.
Summary
- Laurence W. Lytton, an individual, has reported beneficial ownership of 9,463,442 shares of Common Stock in Xtant Medical Holdings, Inc.
- This ownership represents 6.8% of the company's outstanding Common Stock.
- The percentage is calculated based on 139,067,915 shares of Common Stock outstanding as of March 3, 2025, as reported in the Issuer's Form 10-K for the fiscal year ended December 31, 2024.
- Mr. Lytton holds sole voting power and sole dispositive power over all 9,463,442 shares.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. It simply reports a significant stake.
Future Outlook
NA
Industry Context
This filing indicates a significant individual investor's stake in Xtant Medical Holdings, Inc., a company operating in the medical device and biotechnology sector. Such disclosures are common and provide transparency regarding major shareholder positions, which can sometimes signal investor confidence or strategic interest within the industry.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual ownership stake, which can influence market perception and potentially signal investor confidence or interest.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Fiscal year end for which Xtant Medical Holdings, Inc. filed its Form 10-K, used to determine outstanding shares. |
| 2025-03-03 | Date on which 139,067,915 shares of Common Stock were reported outstanding by the Issuer. |
| 2025-04-15 | Date of event which requires the filing of this statement. |
| 2025-04-16 | Date the Schedule 13G statement was signed and filed. |
Keywords
Xtant Medical Holdings Inc., Laurence W. Lytton, Beneficial Ownership, Common Stock, SEC Filing, Schedule 13G, Shareholder, Medical Devices, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.